Resultats de la cerca - Yoo‐Na Kim
- Mostrar 1 - 6 resultats de 6
-
1
-
2
-
3
-
4
Investigation of PARP Inhibitor Resistance Based on Serially Collected Circulating Tumor DNA in Patients With <i>BRCA</i>-Mutated Ovarian Cancer per Yoo‐Na Kim, Yeeun Shim, Jieun Seo, Zisun Choi, Yong Jae Lee, Saeam Shin, Sang Wun Kim, Sunghoon Kim, Jong Rak Choi, Jung‐Yun Lee, Seung‐Tae Lee
Publicat 2023Artigo -
5
Triplet maintenance therapy of olaparib, pembrolizumab and bevacizumab in women with BRCA wild-type, platinum-sensitive recurrent ovarian cancer: the multicenter, single-arm phase... per Yoo‐Na Kim, Boram Park, Jae‐Weon Kim, Byoung Gie Kim, Sang Wun Kim, Hee Seung Kim, Chel Hun Choi, Myong Cheol Lim, Natalie Ngoi, David S.P. Tan, Jung‐Yun Lee
Publicat 2023Artigo -
6
The WID-BC-index identifies women with primary poor prognostic breast cancer based on DNA methylation in cervical samples per James E. Barrett, Chiara Herzog, Allison Jones, Olivia C. Leavy, Iona Evans, Susanne Knapp, Daniel Reisel, Tatiana Nazarenko, Yoo‐Na Kim, D. Franchi, Andy Ryan, Joanna Franks, Line Bjørge, Michal Zikán, David Cibula, Nadia Harbeck, Nicoletta Colombo, Frank Dudbridge, J. Louise Jones, Karin Sundström, Joakim Dillner, Angelique Flöter Rådestad, Kristina Gemzell‐Danielsson, Nora Pashayan, Martin Widschwendter
Publicat 2022Artigo
Eines de cerca:
Matèries relacionades
Biology
Medicine
Cancer
Gene
Genetics
Oncology
Cancer research
Internal medicine
Ovarian cancer
Pathology
Biochemistry
Breast cancer
Mutation
ARID1A
Advanced maternal age
Adverse effect
Apoptosis
Bevacizumab
Birth weight
Body mass index
Brain tumor
Cell
Cell biology
Cell culture
Cervical cancer
Chemotherapy
Clinical endpoint
Clinical trial
Cohort study
Colorectal cancer